Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuromolecular Med ; 14(4): 349-61, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22798222

RESUMO

The central nervous system (CNS)-based symptoms of Gulf War Illness (GWI) include motor dysfunction, anxiety, and cognitive impairment. Gulf War (GW) agents, such as pyridostigmine bromide (PB), permethrin (PER), N,N-diethyl-meta-toluamide (DEET), and stress, are among the contributory factors to the pathobiology of GWI. This study characterizes disturbances in phosphocholine-containing lipids that accompany neurobehavioral and neuropathological features associated with GW agent exposure. Exposed mice received PB orally, dermal application of PER and DEET and restraint stress daily for 28 days, while controls received vehicle during this period. Neurobehavioral studies included the rotarod, open field, and Morris water maze tests. Histopathological assessments included glial fibrillary acid protein, CD45, and Nissl staining. Liquid chromatography/mass spectrometry with source collision-induced dissociation in negative and positive ionization scanning modes was performed to characterize brain phosphatidylcholine (PC) and sphingomyelin (SM). A significant increase in ether containing PC (ePC34:0, ePC36:2, and ePC36:1) or long-chain fatty acid-containing PC (38:1, 40:4, 40:2) was observed in exposed mice compared with controls. Among differentially expressed PCs, levels of those with monounsaturated fatty acids were more affected than those with saturated and polyunsaturated fatty acids. Sensorimotor deficits and anxiety, together with an increase in astrocytosis, were observed in exposed mice compared with controls. These lipid changes suggest that alterations in peroxisomal pathways and stearoyl-CoA desaturase activity accompany neurobehavioral and neuropathological changes after GW agent exposure and represent possible treatment targets for the CNS symptoms of GWI.


Assuntos
Ansiedade/induzido quimicamente , Ataxia/induzido quimicamente , Química Encefálica/efeitos dos fármacos , Córtex Cerebral/química , DEET/toxicidade , Giro Denteado/química , Modelos Animais de Doenças , Permetrina/toxicidade , Síndrome do Golfo Pérsico/metabolismo , Fosfatidilcolinas/metabolismo , Brometo de Piridostigmina/toxicidade , Transtornos de Sensação/induzido quimicamente , Esfingomielinas/metabolismo , Animais , Ansiedade/metabolismo , Ansiedade/patologia , Ataxia/metabolismo , Ataxia/patologia , Córtex Cerebral/patologia , Giro Denteado/patologia , Comportamento Exploratório/efeitos dos fármacos , Ácidos Graxos/metabolismo , Feminino , Gliose/induzido quimicamente , Gliose/metabolismo , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Proteínas do Tecido Nervoso/metabolismo , Peroxissomos/metabolismo , Desempenho Psicomotor/efeitos dos fármacos , Distribuição Aleatória , Teste de Desempenho do Rota-Rod , Transtornos de Sensação/metabolismo , Transtornos de Sensação/patologia , Estearoil-CoA Dessaturase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...